Clinical Trial Update: Unfractioned Heparin for Treatment of Sepsis Caused by Abdominal Infection [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating unfractionated heparin as a treatment for sepsis caused by abdominal infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: The Third Xiangya Hospital of Central South University | Conditions: Sepsis, Gram-Negative Bacterial Infections | Phase 3 | Status: UNKNOWN